Back to Brevan Howard Capital Management LP Brevan Howard Capital Management LP

AGIO

Showing 8 of 11 quarters

Position history for Brevan Howard Capital Management LPBrevan Howard Capital Management LP's holdings in Agios Pharmaceuticals, Inc.

Yes. Brevan Howard holds 9,290 shares of AGIO (Agios Pharmaceuticals), worth $344,752, as of its Q2 2026 13F filing. It reduced the position by 15,179 shares (-62.0%) from Q1 2026. Brevan Howard has held AGIO since Q2 2025, across 5 quarterly 13F filings.

Current Value

$344,752

Current Shares

9,290

Total Value Change

-$131,849

Total Shares Change

-1,437

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
9,290
-62.0%
$344,7520.0%$37.11
0
2026-Q1
Increased
24,469
+26.6%
$866,5700.0%$33.83
31
2025-Q4
Increased
19,336
+60.2%
$526,3260.0%$27.22
35
2025-Q3
Decreased
12,071
-58.6%
$484,5300.0%$40.14
0
2025-Q2
New
29,177
-
$970,4270.0%$33.26
35
2025-Q1
Exited
0
-100.0%
$00.0%$29.30
0
2024-Q4
Increased
47,326
+341.2%
$1.6M0.0%$32.86
41
2024-Q3
Decreased
10,727
-22.4%
$476,6010.0%$44.43
0

Other major holders of AGIO: FMR LLC, Wellington Management Group LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used